PUBLIC COMPANY
save$KODKodiak Sciences Inc.
$KOD43.41+3.09%Palo Alto, CA, USupdated 6h ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Active trials
- phase3A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
- phase3A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
- phase3A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
- phase3A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)
- phase3A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)
- phase3A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
- phase3A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
- phase3A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Apr 15, 26option exerciseBORGESON JOHN A. · Chief Financial Officer28,614 sh
- Apr 15, 26option exerciseBORGESON JOHN A. · Chief Financial Officer28,614 sh
- Apr 2, 26option exerciseBORGESON JOHN A. · Chief Financial Officer30,000 sh
- Apr 2, 26option exerciseBORGESON JOHN A. · Chief Financial Officer30,000 sh
- Mar 25, 26option exercisePERLROTH VICTOR · Chairman and CEO300,000 sh
- Mar 25, 26option exercisePERLROTH VICTOR · Chairman and CEO300,000 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 24m ago
Found something off?
comments(0)
5-min edit window · permanent after that